Choline Intake and Risk of Lethal Prostate Cancer: Incidence and Survival

Overview

Journal Am J Clin Nutr

Publisher Elsevier

Specialty Nutritional Sciences

Date 2012 Sep 7

PMID 22952174

Citations 31

Authors

Erin L Richman

Stacey A Kenfield

Meir J Stampfer

Edward L Giovannucci

Steven H Zeisel

Walter C Willett

June M Chan

Affiliations

Soon will be listed here.

Abstract

Background: Meat, milk, and eggs have been inconsistently associated with the risk of advanced prostate cancer. These foods are sources of choline-a nutrient that may affect prostate cancer progression through cell membrane function and one-carbon metabolism. No study has examined dietary choline and the risk of lethal prostate cancer.

Objective: Our objective was to examine whether dietary choline, choline-containing compounds, and betaine (a choline metabolite) increase the risk of lethal prostate cancer.

Design: We prospectively examined the intake of these nutrients and the risk of lethal prostate cancer among 47,896 men in the Health Professionals Follow-Up Study. In a case-only survival analysis, we examined the postdiagnostic intake of these nutrients and the risk of lethal prostate cancer among 4282 men with an initial diagnosis of nonmetastatic disease during follow-up. Diet was assessed with a validated questionnaire 6 times during 22 y of follow-up.

Results: In the incidence analysis, we observed 695 lethal prostate cancers during 879,627 person-years. Men in the highest quintile of choline intake had a 70% increased risk of lethal prostate cancer (HR: 1.70; 95% CI: 1.18, 2.45; P-trend = 0.005). In the case-only survival analysis, we observed 271 lethal cases during 33,679 person-years. Postdiagnostic choline intake was not statistically significantly associated with the risk of lethal prostate cancer (HR for quintile 5 compared with quintile 1: 1.69; 95% CI: 0.93, 3.09; P-trend = 0.20).

Conclusion: Of the 47,896 men in our study population, choline intake was associated with an increased risk of lethal prostate cancer.

Citing Articles

Gut microbiota derived metabolite trimethylamine N-oxide influences prostate cancer progression via the p38/HMOX1 pathway.

Zhou Y, Lv J, Jin S, Fu C, Liu B, Shen Y Front Pharmacol. 2025; 15():1526051.

PMID: 39850572 PMC: 11754881. DOI: 10.3389/fphar.2024.1526051.

Obesity, dietary interventions and microbiome alterations in the development and progression of prostate cancer.

Trecarten S, Liss M, Hamilton-Reeves J, DiGiovanni J Front Immunol. 2025; 15():1448116.

PMID: 39840030 PMC: 11747771. DOI: 10.3389/fimmu.2024.1448116.

Emerging Biomarkers in Metabolomics: Advancements in Precision Health and Disease Diagnosis.

Vo D, Trinh K Int J Mol Sci. 2024; 25(23).

PMID: 39684900 PMC: 11642057. DOI: 10.3390/ijms252313190.

Prostate Cancer: A Review of Genetics, Current Biomarkers and Personalised Treatments.

Wilson T, Zishiri O Cancer Rep (Hoboken). 2024; 7(10):e70016.

PMID: 39410867 PMC: 11480670. DOI: 10.1002/cnr2.70016.

Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.

Pallozzi M, De Gaetano V, Di Tommaso N, Cerrito L, Santopaolo F, Stella L Nutrients. 2024; 16(14).

PMID: 39064815 PMC: 11280141. DOI: 10.3390/nu16142372.

References

Sanchez C, Hooper E, Garry P, Goodwin J, Goodwin J . The relationship between dietary intake of choline, choline serum levels, and cognitive function in healthy elderly persons. J Am Geriatr Soc. 1984; 32(3):208-12. DOI: 10.1111/j.1532-5415.1984.tb02004.x. View

Deuster P, Singh A, Coll R, Hyde D, Becker W . Choline ingestion does not modify physical or cognitive performance. Mil Med. 2002; 167(12):1020-5. View

Ramirez de Molina A, Rodriguez-Gonzalez A, Gutierrez R, Martinez-Pineiro L, Sanchez J, Bonilla F . Overexpression of choline kinase is a frequent feature in human tumor-derived cell lines and in lung, prostate, and colorectal human cancers. Biochem Biophys Res Commun. 2002; 296(3):580-3. DOI: 10.1016/s0006-291x(02)00920-8. View

Richman E, Kenfield S, Stampfer M, Giovannucci E, Chan J . Egg, red meat, and poultry intake and risk of lethal prostate cancer in the prostate-specific antigen-era: incidence and survival. Cancer Prev Res (Phila). 2011; 4(12):2110-21. PMC: 3232297. DOI: 10.1158/1940-6207.CAPR-11-0354. View

Astorg P . Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control. 2004; 15(4):367-86. DOI: 10.1023/B:CACO.0000027498.94238.a3. View

Richman E, Stampfer M, Paciorek A, Broering J, Carroll P, Chan J . Intakes of meat, fish, poultry, and eggs and risk of prostate cancer progression. Am J Clin Nutr. 2010; 91(3):712-21. PMC: 3132069. DOI: 10.3945/ajcn.2009.28474. View

Ackerstaff E, Pflug B, Nelson J, Bhujwalla Z . Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells. Cancer Res. 2001; 61(9):3599-603. View

Zeisel S, Blusztajn J . Choline and human nutrition. Annu Rev Nutr. 1994; 14:269-96. DOI: 10.1146/annurev.nu.14.070194.001413. View

Fioravanti M, Yanagi M . Cytidinediphosphocholine (CDP choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev. 2004; (2):CD000269. DOI: 10.1002/14651858.CD000269.pub2. View

10.

Raina K, Serkova N, Agarwal R . Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study. Cancer Res. 2009; 69(9):3731-5. PMC: 2679526. DOI: 10.1158/0008-5472.CAN-09-0096. View

11.

Cho E, Zeisel S, Jacques P, Selhub J, Dougherty L, Colditz G . Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study. Am J Clin Nutr. 2006; 83(4):905-11. PMC: 2430728. DOI: 10.1093/ajcn/83.4.905. View

12.

Rumsby M, Schmitt J, Sharrard M, Rodrigues G, Stower M, Maitland N . Human prostate cell lines from normal and tumourigenic epithelia differ in the pattern and control of choline lipid headgroups released into the medium on stimulation of protein kinase C. Br J Cancer. 2011; 104(4):673-84. PMC: 3049586. DOI: 10.1038/sj.bjc.6606077. View

13.

Buchman A, Sohel M, Brown M, JENDEN D, Ahn C, Roch M . Verbal and visual memory improve after choline supplementation in long-term total parenteral nutrition: a pilot study. JPEN J Parenter Enteral Nutr. 2001; 25(1):30-5. DOI: 10.1177/014860710102500130. View

14.

Veenema K, Solis C, Li R, Wang W, Maletz C, Abratte C . Adequate Intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load. Am J Clin Nutr. 2008; 88(3):685-92. PMC: 2637180. DOI: 10.1093/ajcn/88.3.685. View

15.

Giovannucci E, Liu Y, Platz E, Stampfer M, Willett W . Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007; 121(7):1571-8. PMC: 2430098. DOI: 10.1002/ijc.22788. View

16.

Al-Saffar N, Jackson L, Raynaud F, Clarke P, Ramirez de Molina A, Lacal J . The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. Cancer Res. 2010; 70(13):5507-17. PMC: 2896552. DOI: 10.1158/0008-5472.CAN-09-4476. View

17.

Keshari K, Tsachres H, Iman R, Delos Santos L, Tabatabai Z, Shinohara K . Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed. 2011; 24(6):691-9. PMC: 3653775. DOI: 10.1002/nbm.1738. View

18.

Zeisel S, da Costa K . Choline: an essential nutrient for public health. Nutr Rev. 2009; 67(11):615-23. PMC: 2782876. DOI: 10.1111/j.1753-4887.2009.00246.x. View

19.

Tessitore L, Marengo B, Vance D, Papotti M, Mussa A, Daidone M . Expression of phosphatidylethanolamine N-methyltransferase in human hepatocellular carcinomas. Oncology. 2003; 65(2):152-8. DOI: 10.1159/000072341. View

20.

Chan J, Gann P, Giovannucci E . Role of diet in prostate cancer development and progression. J Clin Oncol. 2005; 23(32):8152-60. DOI: 10.1200/JCO.2005.03.1492. View